The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B
Endocrine Reviews · 04.01.2024 · 45 (1) · 30-68
DOI: 10.1210/endrev/bnad023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 20.07.2023. Verfasst von Bijal Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College School of Medicine, Imperial College London…. Hauptthemen laut MEDLINE: Neurokinin B, Kisspeptins. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 338 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MRC Clinical Research Training Fellowship, NIHR Academic Clinical Fellowship Award, NIHR Academic Clinical Lectureship in Endocrinology.
Abstract (Originalsprache)
Kisspeptin (KP) and neurokinin B (NKB) are neuropeptides that govern the reproductive endocrine axis through regulating hypothalamic gonadotropin-releasing hormone (GnRH) neuronal activity and pulsatile GnRH secretion. Their critical role in reproductive health was first identified after inactivating variants in genes encoding for KP or NKB signaling were shown to result in congenital hypogonadotropic hypogonadism and a failure of pubertal development. Over the past 2 decades since their discovery, a wealth of evidence from both basic and translational research has laid the foundation for potential therapeutic applications. Beyond KP's function in the hypothalamus, it is also expressed in the placenta, liver, pancreas, adipose tissue, bone, and limbic regions, giving rise to several avenues of research for use in the diagnosis and treatment of pregnancy, metabolic, liver, bone, and behavioral disorders. The role played by NKB in stimulating the hypothalamic thermoregulatory center to mediate menopausal hot flashes has led to the development of medications that antagonize its action as a novel nonsteroidal therapeutic agent for this indication. Furthermore, the ability of NKB antagonism to partially suppress (but not abolish) the reproductive endocrine axis has supported its potential use for the treatment of various reproductive disorders including polycystic ovary syndrome, uterine fibroids, and endometriosis. This review will provide a comprehensive up-to-date overview of the preclinical and clinical data that have paved the way for the development of diagnostic and therapeutic applications of KP and NKB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College School of Medicine, Imperial College London, London, W12 0NN, UK.
- Department of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, 72 Du Cane Rd, London, W12 0HS, UK.
ORCID-Profile: Alexander N Comninos, Ali Abbara, Waljit S Dhillo
Förderung
- MRC Clinical Research Training Fellowship
- NIHR Academic Clinical Fellowship Award
- NIHR Academic Clinical Lectureship in Endocrinology
- NIHR Biomedical Research Centre Funding Scheme
- NHS
- NIHR Clinician Scientist
- NIHR Research Professorship
Zitieren
APA
Patel, B., Koysombat, K., Mills, E. G., Tsoutsouki, J., Comninos, A. N., Abbara, A., & Dhillo, W. S. (2024). The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B. Endocrine Reviews, 45(1), 30-68. https://doi.org/10.1210/endrev/bnad023
Vancouver
Patel B, Koysombat K, Mills EG, Tsoutsouki J, Comninos AN, Abbara A, et al. The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B. Endocrine Reviews. 2024;45(1):30-68. doi:10.1210/endrev/bnad023
BibTeX
@article{Patel2024,
author = {Patel, Bijal and Koysombat, Kanyada and Mills, Edouard G and Tsoutsouki, Jovanna and Comninos, Alexander N and Abbara, Ali and Dhillo, Waljit S},
title = {The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B},
journal = {Endocrine Reviews},
year = {2024},
volume = {45},
number = {1},
pages = {30--68},
doi = {10.1210/endrev/bnad023}
}
EUVIMED